- Home
- TLYS vs IKT Comparison
TLYS vs IKT Comparison
Compare TLYS & IKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLYS
- IKT
- Stock Information
- Founded
- TLYS 1982
- IKT 2008
- Country
- TLYS United States
- IKT United States
- Employees
- TLYS N/A
- IKT N/A
- Industry
- TLYS Clothing/Shoe/Accessory Stores
- IKT Biotechnology: Pharmaceutical Preparations
- Sector
- TLYS Consumer Discretionary
- IKT Health Care
- Exchange
- TLYS Nasdaq
- IKT Nasdaq
- Market Cap
- TLYS 133.9M
- IKT 159.2M
- IPO Year
- TLYS 2012
- IKT 2020
- Fundamental
- Price
- TLYS $3.37
- IKT $3.97
- Analyst Decision
- TLYS Hold
- IKT Strong Buy
- Analyst Count
- TLYS 2
- IKT 2
- Target Price
- TLYS $5.50
- IKT $6.50
- AVG Volume (30 Days)
- TLYS 62.1K
- IKT 292.3K
- Earning Date
- TLYS 12-05-2024
- IKT 11-14-2024
- Dividend Yield
- TLYS N/A
- IKT N/A
- EPS Growth
- TLYS N/A
- IKT N/A
- EPS
- TLYS N/A
- IKT N/A
- Revenue
- TLYS $595,185,000.00
- IKT $1.00
- Revenue This Year
- TLYS N/A
- IKT N/A
- Revenue Next Year
- TLYS $3.90
- IKT N/A
- P/E Ratio
- TLYS N/A
- IKT N/A
- Revenue Growth
- TLYS N/A
- IKT N/A
- 52 Week Low
- TLYS $3.30
- IKT $1.12
- 52 Week High
- TLYS $7.79
- IKT $4.14
- Technical
- Relative Strength Index (RSI)
- TLYS 33.34
- IKT 79.35
- Support Level
- TLYS $3.30
- IKT $3.12
- Resistance Level
- TLYS $3.64
- IKT $3.61
- Average True Range (ATR)
- TLYS 0.30
- IKT 0.40
- MACD
- TLYS -0.09
- IKT 0.09
- Stochastic Oscillator
- TLYS 4.76
- IKT 90.29
About TLYS Tilly's Inc.
Tilly's Inc works as a specialty retailer of casual apparel, footwear, and accessories for young men, young women, boys, and girls. It offers an unparalleled selection of relevant brands, styles, colors, sizes, and price points. It delivers branded fashion, and core styles for tops, outerwear, bottoms, and dresses. It also provides backpacks, hats, sunglasses, headphones, handbags, watches, and jewelry. It markets its products under the brand names of Vans, RVCA, Adidas, Nike SB, and Hurley among others. It operates its stores in malls, lifestyle centers, power centers, community centers, outlet centers, street-front locations, and also through e-commerce.
About IKT Inhibikase Therapeutics Inc.
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease ("PD"), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.